Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.99526
Revised: September 4, 2024
Accepted: November 8, 2024
Published online: January 15, 2025
Processing time: 128 Days and 16.4 Hours
At present, the existing internal medicine drug treatment can alleviate the high glucose toxicity of patients to a certain extent, to explore the efficacy of laparoscopic jejunoileal side to side anastomosis in the treatment of type 2 diabetes, the report is as follows.
To investigate the effect of jejunoileal side-to-side anastomosis on metabolic parameters in patients with type 2 diabetes mellitus (T2DM).
We retrospectively analyzed the clinical data of 78 patients with T2DM who were treated via jejunoileal lateral anastomosis. Metabolic indicators were collected preoperatively, as well as at 3 and 6 months postoperative. The metabolic in
SBP, DBP, PBG, HbA1c, LDL-C, and TG were all significantly lower 3 months postoperative vs preoperative values; body weight, BMI, SBP, DBP, FBG, PBG, HbA1c, TC, TG, UA, and HOMA-IR values were all significantly lower 6 months postoperative vs at 3 months; and PCP, Fins, Pins, and HOMA-β were all significantly higher 6 months postoperative vs at 3 months (all P < 0.05).
Side-to-side anastomosis of the jejunum and ileum can effectively treat T2DM and improve the metabolic index levels associated with it.
Core Tip: This study investigates the impact of jejunal ileal side to side anastomosis on metabolic parameters in patients with type 2 diabetes. The procedure showed significant improvements in patients' metabolic indicators such as body mass index, blood pressure, blood glucose, insulin resistance index, and cholesterol levels at 3 and 6 months post-surgery. This suggests that jejunal ileal side to side anastomosis could be an effective treatment for managing type 2 diabetes and improving metabolic health.